Redmile Group, LLC 13F Holdings
CIK 0001425738 · SAN FRANCISCO, CA
As of Sep 30, 2025, Redmile Group, LLC reported 40 positions worth
CIK 0001425738 · SAN FRANCISCO, CA
As of Sep 30, 2025, Redmile Group, LLC reported 40 positions worth
.0B in its SEC Form 13F filing.
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORP | SRRK | Healthcare | 3,904,456 | 45.4M | 14.15% |
| KRYSTAL BIOTECH INC | KRYS | Healthcare | 661,388 | 16.8M | 11.36% |
| STOKE THERAPEUTICS INC | STOK | Healthcare | 4,175,542 | $98.1M | 9.55% |
| ZYMEWORKS INC | ZYME | Healthcare | 3,705,750 | $63.3M | 6.16% |
| ADC THERAPEUTICS SA | ADCT | Healthcare | 15,666,731 | $62.7M | 6.10% |
| IMMUNOME INC | IMNM | — | 5,023,385 | $58.8M | 5.72% |
| LIVANOVA PLC | LIVN | Healthcare | 926,799 | $48.5M | 4.72% |
| REGENXBIO INC | RGNX | Healthcare | 4,693,389 | $45.3M | 4.41% |
| AKERO THERAPEUTICS INC | AKRO | Healthcare | 747,818 | $35.5M | 3.45% |
| NURIX THERAPEUTICS INC | NRIX | Healthcare | 3,678,394 | $34.0M | 3.31% |
| BEAM THERAPEUTICS INC | BEAM | Healthcare | 1,387,559 | $33.7M | 3.28% |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 2,209,118 | $31.7M | 3.09% |
| ABSCI CORP | ABSI | Healthcare | 8,253,316 | $25.1M | 2.44% |
| NEUROGENE INC | NGNE | Healthcare | 1,299,022 | $22.5M | 2.19% |
| 89BIO INC | ETNB | Healthcare | 1,473,136 | $21.7M | 2.11% |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 742,017 | $20.2M | 1.96% |
| ANNEXON INC | ANNX | Healthcare | 6,300,644 | 9.2M | 1.87% |
| FATE THERAPEUTICS INC | FATE | Healthcare | 12,872,946 | 6.2M | 1.58% |
| RAPT THERAPEUTICS INC | RAPT | Healthcare | 552,594 | 4.3M | 1.39% |
| SHATTUCK LABS INC | STTK | Healthcare | 5,539,724 | 3.2M | 1.29% |
| SOLID BIOSCIENCES INC | SLDB | Healthcare | 1,899,342 | 1.7M | 1.14% |
| SILENCE THERAPEUTICS PLC | SLN | Healthcare | 2,164,777 | 1.2M | 1.09% |
| NUVATION BIO INC | NUVB | Healthcare | 3,031,009 | 1.2M | 1.09% |
| KEROS THERAPEUTICS INC | KROS | Healthcare | 552,506 | $8.7M | 0.85% |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 327,008 | $8.5M | 0.82% |